Insider Transactions in Q1 2023 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,290
-0.46%
|
$19,740
$6.26 P/Share
|
|
Mar 29
2023
|
Richard A. Cross SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
1,710
-0.43%
|
$10,260
$6.11 P/Share
|
|
Mar 29
2023
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,506
-1.45%
|
$207,036
$6.11 P/Share
|
|
Mar 29
2023
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
7,178
-0.37%
|
$43,068
$6.11 P/Share
|
|
Mar 29
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
3,286
-0.3%
|
$19,716
$6.11 P/Share
|
|
Mar 29
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,312
-0.74%
|
$31,872
$6.11 P/Share
|
|
Mar 14
2023
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
2,400
-0.12%
|
-
|
|
Mar 14
2023
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,006
-1.02%
|
$120,036
$6.33 P/Share
|
|
Mar 14
2023
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
39,101
-1.62%
|
$234,606
$6.33 P/Share
|
|
Mar 14
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
14,164
-1.28%
|
$84,984
$6.33 P/Share
|
|
Mar 14
2023
|
Richard A. Cross SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
5,516
-1.38%
|
$33,096
$6.33 P/Share
|
|
Mar 14
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,470
-1.84%
|
$80,820
$6.33 P/Share
|
|
Mar 09
2023
|
Joseph S Konowiecki Director |
BUY
Open market or private purchase
|
Direct |
100,000
+8.94%
|
$600,000
$6.62 P/Share
|
|
Mar 08
2023
|
Thomas J. Carella Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+25.6%
|
-
|
|
Mar 08
2023
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+10.86%
|
-
|
|
Mar 08
2023
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+6.47%
|
-
|
|
Mar 08
2023
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,337
+29.77%
|
-
|
|
Mar 08
2023
|
Jeffrey H Margolis Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+22.65%
|
-
|
|
Mar 08
2023
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+20.78%
|
-
|
|
Mar 08
2023
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+33.49%
|
-
|
|
Mar 08
2023
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+30.16%
|
-
|
|
Mar 08
2023
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,337
+29.77%
|
-
|
|
Mar 02
2023
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
6,800
-0.35%
|
-
|
|
Feb 01
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.9%
|
$120,000
$12.19 P/Share
|
|
Jan 18
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,100
-0.21%
|
$14,300
$13.01 P/Share
|
|
Jan 18
2023
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
1,100
-0.04%
|
$14,300
$13.01 P/Share
|
|
Jan 18
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
1,125
-0.1%
|
$14,625
$13.01 P/Share
|
|
Jan 17
2023
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
5,000
-0.25%
|
$60,000
$12.54 P/Share
|
|
Jan 13
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.8%
|
$108,000
$12.09 P/Share
|
|
Jan 03
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.09%
|
$12,000
$12.01 P/Share
|